Ambry Genetics

Ambry Genetics

Genetic testing solutions to empower healthcare professionals and patients with actionable insights for personalized care.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round
N/A

€0.0

round
*

$600m

Valuation: $600m

Acquisition
Total Funding000k
INCJ
INCJ(exited)
Notes (0)
More about Ambry Genetics
Edit

Ambry Genetics is a leading provider of advanced genetic testing solutions, offering a comprehensive menu of tests focused on hereditary cancer, heart conditions, neurological disorders, and rare diseases. The company leverages cutting-edge technology, including DNA and RNA analysis, to deliver accurate and actionable insights to healthcare professionals and patients.

With a history spanning over two decades, Ambry Genetics has established itself as an innovator in the field of clinical genetic testing. Their services enable healthcare providers to make more informed decisions about patient care, potentially leading to earlier detection, prevention, and targeted treatment of genetic conditions.

The company's commitment to scientific excellence is evident in their partnerships with leading genetic researchers and institutions. Ambry Genetics also prioritizes patient accessibility, working with insurance providers to ensure coverage for their tests and offering financial assistance programs for those who need it.

By combining advanced technology with a patient-focused approach, Ambry Genetics is at the forefront of the precision medicine revolution, helping to shape the future of personalized healthcare and improve outcomes for individuals at risk of or affected by inherited diseases.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Ambry Genetics

Edit
Progeny Software
ACQUISITION by Ambry Genetics Apr 2015